SCHEMBL30681726

SCHEMBL30681726

Cc1scc(S(=O)(=O)Nc2ccc(F)c(N)c2F)c1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ VSIR Q9H7M9 1/20 0.37
▸ TP53 P04637 1/20 0.36
▸ PTGES2 Q9H7Z7 2/20 0.35
▸ CCR2 P41597 3/20 0.35
▸ FABP4 P15090 1/20 0.34
▸ IDH1 O75874 1/20 0.34
▸ ERN1 O75460 1/20 0.34
▸ SLC40A1 Q9NP59 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ APEX1 P27695 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ CASP6 P55212 1/20 0.33
▸ CTDSP1 Q9GZU7 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ EIF2AK3 Q9NZJ5 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27146891 1.00 VSIR (0.37) VSIRTP53PTGES2CCR2FABP4
SCHEMBL29335302 0.80 PTGES2 (0.41) PTGES2CCR2FABP4IDH1SLC40A1
SCHEMBL29335303 0.78 ACLY (0.39) PTGES2CCR2FABP4IDH1SLC40A1
SCHEMBL29335256 0.78 SLC40A1 (0.54) TP53PTGES2CCR2SLC40A1POLB
SCHEMBL30681721 0.77 CA1 (0.37) TP53PTGES2CCR2ERN1EIF2AK3
SCHEMBL27147321 0.77 CA1 (0.37) TP53PTGES2CCR2ERN1EIF2AK3
SCHEMBL29335304 0.76 CCR2 (0.44) TP53PTGES2CCR2ERN1SLC40A1
SCHEMBL29335307 0.76 SLC40A1 (0.43) PTGES2ERN1SLC40A1CYP2C9
SCHEMBL3022491 0.76 PTGES2 (0.52) PTGES2CCR2FABP4TSHRHPGD
SCHEMBL29335255 0.75 SLC40A1 (0.51) PTGES2CCR2SLC40A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117177973-A Pyrido [3,2-D ] pyrimidine compounds and their use for the treatment of proliferative disorders 蒙特利尔大学 2023-12-05 — — CN disclosed
Send feedback